Literature DB >> 1534693

Clinical features of human infection with Scedosporium inflatum.

G M Wood1, J G McCormack, D B Muir, D H Ellis, M F Ridley, R Pritchard, M Harrison.   

Abstract

We report on 17 Australian cases of human infection or colonization with Scedosporium inflatum. The spectrum of clinical manifestations was similar to that in infection caused by Scedosporium apiospermum. The patients were classified into three groups. Four immunocompetent patients who presented with localized infections of a joint, nail bed, eye, or sphenoidal sinus made up the first group. Our first case, in a boy with posttraumatic septic arthritis, responded to surgical drainage with amphotericin B followed by treatment with itraconazole. The other three cases were cured by surgery alone. The second group consisted of five immunocompromised patients who presented with disseminated infections in a variety of sites. Four of these patients did not respond to antifungal therapy and died. The fifth apparently responded to antifungal drugs after correction of his neutropenia. The third group included eight patients with asymptomatic colonization in the external ear (five cases) or respiratory secretions (three cases). The nine isolates of S. inflatum tested by both disk and agar dilution methods were resistant to antifungal drugs. In our first case, which responded clinically to itraconazole, the MIC of this drug for the fungal isolate was 25 micrograms/mL. Thus S. inflatum can cause a broad spectrum of human infections whose severity and prognosis depend largely on the host's immune status.

Entities:  

Mesh:

Year:  1992        PMID: 1534693     DOI: 10.1093/clinids/14.5.1027

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  27 in total

1.  Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis.

Authors:  R San Millán; G Quindós; J Garaizar; R Salesa; J Guarro; J Pontón
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.

Authors:  Joseph Meletiadis; Jacques F G M Meis; Johan W Mouton; Juan Luis Rodriquez-Tudela; J Peter Donnelly; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Fatal Scedosporium prolificans infection in a leukemic patient.

Authors:  M C Feltkamp; M J Kersten; J van der Lelie; J D Burggraaf; G S de Hoog; E J Kuijper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

Review 4.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

5.  Disseminated infection caused by Scedosporium prolificans in a patient with acute multilineal leukemia.

Authors:  J de Batlle; M Motjé; R Balanzà; R Guardia; R Ortiz
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media.

Authors:  C C Blyth; A Harun; P G Middleton; S Sleiman; O Lee; T C Sorrell; W Meyer; S C A Chen
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

7.  Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.

Authors:  M Simitsopoulou; C Gil-Lamaignere; N Avramidis; A Maloukou; S Lekkas; E Havlova; L Kourounaki; D Loebenberg; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 8.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum.

Authors:  Laurence Delhaes; Azian Harun; Sharon C A Chen; Quoc Nguyen; Monica Slavin; Christopher H Heath; Krystyna Maszewska; Catriona Halliday; Vincent Robert; Tania C Sorrell; Wieland Meyer
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Infection with Scedosporium apiospermum and S. prolificans, Australia.

Authors:  Louise Cooley; Denis Spelman; Karin Thursky; Monica Slavin
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.